Literature DB >> 9174127

Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).

M E Miele1, A De La Rosa, J H Lee, D J Hicks, J U Dennis, P S Steeg, D R Welch.   

Abstract

Metastasis is suppressed more than 95% following microcell-mediated transfer of a single copy of neomycin-tagged human chromosome 6 (neo6) into the human melanoma cell lines C8161 and MelJuSo. Concomitant with metastasis suppression is upregulation of NME1 (Nm23-H1) mRNA and protein expression. The purposes of this study were to determine whether NME1 expression was responsible for metastasis suppression in neo6/melanoma hybrids, and whether genes on chromosome 6 regulate NME1. Using neo6/C8161 cells, transfection of CAT reporter constructs linked to the NME1 promoter failed to consistently induce CAT. Therefore, it does not appear that genes on chromosome 6 directly control transcription of NME1. Transfection and overexpression of NME1 in MelJuSo, under the control of the CMV promoter, resulted in 40-80% inhibition of lung metastasis following i.v. inoculation of 2 x 10(5) cells. Only one transfectant of C8161 subclone 9 (C8161cl.9) cells was suppressed for metastasis. Control transfections with pCMVneo or pSV2neo did not suppress metastasis in either cell line. Taken together, these data suggest that NME1 can reduce metastatic potential of some human melanoma cells; but, this inhibitory activity appears to be independent of the metastasis suppression following introduction of chromosome 6 into C8161 and MelJuSo human melanoma cell lines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9174127     DOI: 10.1023/a:1018473415458

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  36 in total

1.  Nm23 protein expression in thyroid neoplasms.

Authors:  J A Royds; P B Silcocks; R C Rees; T J Stephenson
Journal:  Pathologica       Date:  1994-06

2.  The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.

Authors:  H Jiang; J Lin; Z Z Su; M Herlyn; R S Kerbel; B E Weissman; D R Welch; P B Fisher
Journal:  Oncogene       Date:  1995-05-04       Impact factor: 9.867

3.  Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer.

Authors:  Y Tokunaga; T Urano; K Furukawa; H Kondo; T Kanematsu; H Shiku
Journal:  Int J Cancer       Date:  1993-08-19       Impact factor: 7.396

Review 4.  The potential roles of nm23 in cancer metastasis and cellular differentiation.

Authors:  N J MacDonald; A de la Rosa; P S Steeg
Journal:  Eur J Cancer       Date:  1995 Jul-Aug       Impact factor: 9.162

5.  Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms.

Authors:  R Radinsky; H Z Weisberg; A N Staroselsky; I J Fidler
Journal:  Cancer Res       Date:  1992-10-15       Impact factor: 12.701

6.  SOD2 (MnSOD) does not suppress tumorigenicity or metastasis of human melanoma C8161 cells.

Authors:  M E Miele; C T McGary; D R Welch
Journal:  Anticancer Res       Date:  1995 Sep-Oct       Impact factor: 2.480

7.  Identification of a second human nm23 gene, nm23-H2.

Authors:  J A Stahl; A Leone; A M Rosengard; L Porter; C R King; P S Steeg
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

8.  Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6.

Authors:  J M Trent; E J Stanbridge; H L McBride; E U Meese; G Casey; D E Araujo; C M Witkowski; R B Nagle
Journal:  Science       Date:  1990-02-02       Impact factor: 47.728

9.  High levels of nm23 expression are related to cell proliferation in human prostate cancer.

Authors:  M Igawa; D B Rukstalis; T Tanabe; G W Chodak
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

10.  Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin.

Authors:  J P Johnson; M Demmer-Dieckmann; T Meo; M R Hadam; G Riethmüller
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

View more
  18 in total

Review 1.  Translational approaches using metastasis suppressor genes.

Authors:  Diane Palmieri; Christine E Horak; Jong-Heun Lee; Douglas O Halverson; Patricia S Steeg
Journal:  J Bioenerg Biomembr       Date:  2006-08       Impact factor: 2.945

2.  MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.

Authors:  Taoufik Ouatas; Susan E Clare; Melanie T Hartsough; Abel De La Rosa; Patricia S Steeg
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

Review 3.  Insights into the biology and prevention of tumor metastasis provided by the Nm23 metastasis suppressor gene.

Authors:  Natascia Marino; Joji Nakayama; Joshua W Collins; Patricia S Steeg
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

4.  The relationship of BRMS1 and RhoGDI2 gene expression to metastatic potential in lineage related human bladder cancer cell lines.

Authors:  M J Seraj; M A Harding; J J Gildea; D R Welch; D Theodorescu
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 5.  Genomics screens for metastasis genes.

Authors:  Jinchun Yan; Qihong Huang
Journal:  Cancer Metastasis Rev       Date:  2012-12       Impact factor: 9.264

6.  Nm23-H1 metastasis suppressor expression level influences the binding properties, stability, and function of the kinase suppressor of Ras1 (KSR1) Erk scaffold in breast carcinoma cells.

Authors:  Massimiliano Salerno; Diane Palmieri; Amina Bouadis; Douglas Halverson; Patricia S Steeg
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 7.  Basic and translational advances in cancer metastasis: Nm23.

Authors:  Taoufik Ouatas; Massimiliano Salerno; Diane Palmieri; Patricia S Steeg
Journal:  J Bioenerg Biomembr       Date:  2003-02       Impact factor: 2.945

8.  In vitro loss of heterozygosity targets the PTEN/MMAC1 gene in melanoma.

Authors:  G P Robertson; F B Furnari; M E Miele; M J Glendening; D R Welch; J W Fountain; T G Lugo; H J Huang; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 9.  Metastasis suppressor genes.

Authors:  Jinchun Yan; Qin Yang; Qihong Huang
Journal:  Histol Histopathol       Date:  2013-03       Impact factor: 2.303

10.  Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.

Authors:  Jean-Claude A Marshall; Joshua W Collins; Joji Nakayama; Christine E Horak; David J Liewehr; Seth M Steinberg; Mary Albaugh; Fernando Vidal-Vanaclocha; Diane Palmieri; Maryse Barbier; Maximilien Murone; Patricia S Steeg
Journal:  J Natl Cancer Inst       Date:  2012-08-21       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.